Molecular pathology of malignant gliomas

DN Louis - Annu. Rev. Pathol. Mech. Dis., 2006 - annualreviews.org
Malignant gliomas, the most common type of primary brain tumor, are a spectrum of tumors
of varying differentiation and malignancy grades. These tumors may arise from neural stem …

Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme

TW Vogel, Z Zhuang, J Li, H Okamoto, M Furuta… - Clinical cancer …, 2005 - AACR
Introduction: Research into the pathogenesis, molecular signaling, and treatment of
glioblastoma multiforme (GBM) has traditionally been conducted using cell lines derived …

[HTML][HTML] Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing

AH Martínez, R Madurga, N García-Romero… - Cancer letters, 2022 - Elsevier
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent
heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper …

[HTML][HTML] Metabolic/proteomic signature defines two glioblastoma subtypes with different clinical outcome

G Marziali, M Signore, M Buccarelli, S Grande… - Scientific reports, 2016 - nature.com
Glioblastoma (GBM) is one of the deadliest human cancers. Because of the extremely
unfavorable prognosis of GBM, it is important to develop more effective diagnostic and …

Protein patterns and proteins that identify subtypes of glioblastoma multiforme

M Furuta, RJ Weil, AO Vortmeyer, S Huang, J Lei… - Oncogene, 2004 - nature.com
Glioblastoma multiforme (GBM) has been subdivided into two types based on clinical and
genetic findings: primary tumors, which arise de novo, and secondary tumors, which …

[HTML][HTML] Decipher the glioblastoma microenvironment: the first milestone for new groundbreaking therapeutic strategies

GN Fanelli, D Grassini, V Ortenzi, F Pasqualetti… - Genes, 2021 - mdpi.com
Glioblastoma (GBM) is the most common primary malignant brain tumour in adults. Despite
the combination of novel therapeutical approaches, it remains a deadly malignancy with an …

Clinical impact of molecular biomarkers in gliomas

T Siegal - Journal of Clinical Neuroscience, 2015 - Elsevier
Abstract The World Health Organization (WHO) classification system for glial tumors
provides guidance as to the predicted course of the disease and choice of treatment …

A molecular genetic model of astrocytoma histopathology

DN Louis - Brain pathology, 1997 - Wiley Online Library
As the molecular events responsible for astrocytoma formation and progression are being
clarified, it is becoming possible to correlate these alterations with the specific …

Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone

JM Lemée, A Clavreul, P Menei - Neuro-oncology, 2015 - academic.oup.com
Glioblastoma (GB) is the most frequent and aggressive primary tumor of the central nervous
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …

Genetics of glioblastoma: a window into its imaging and histopathologic variability

CJ Belden, PA Valdes, C Ran, DA Pastel, BT Harris… - Radiographics, 2011 - pubs.rsna.org
Glioblastoma is a highly malignant brain tumor that relentlessly defies therapy. Efforts over
the past decade have begun to tease out the biochemical details that lead to its aggressive …